文献速递细胞病理与分子病理

常规细胞病理学在儿童精准肿瘤学中的重要作用

The important role of routine cytopathology in pediatric precision oncology.
PubMed 文献 · Cancer Cytopathol · 2021-05-27

该研究对95例儿童精准肿瘤学试验中的129份细胞病理学标本(细胞块)进行H&E和免疫组化染色,并与原发肿瘤形态和免疫表型比较。结果显示60%病例存在肿瘤细胞,29%无肿瘤细胞,11%不确定;含肿瘤细胞的培养物与原肿瘤相似。细胞病理学检查可确保送检高通量药物筛选的样本含代表性肿瘤细胞,使体外药敏数据具有临床转化价值。

要点

  • 细胞病理学评估细胞块可判断高通量药物筛选样本是否含肿瘤细胞。
  • 60%病例检出肿瘤细胞,29%无肿瘤细胞,11%不确定。
  • 含肿瘤细胞的培养物形态与来源肿瘤相似。

核心结论

  • 细胞病理学检查细胞块可行,能提供详细形态学特征。
  • 细胞病理学检查对确保高通量药物筛选样本含代表性肿瘤细胞至关重要。
  • 经细胞病理学验证的培养物药敏数据具有临床转化潜力。

研究设计与样本

  • 对95例患者共129份细胞病理学病例进行H&E和免疫组化染色。
  • 病例为原发肿瘤标本或患者来源异种移植瘤的细胞块制备。
  • 将细胞病理学结果与原发肿瘤形态和免疫组化表型比较。

主要发现

  • 129例中77例(60%)存在肿瘤细胞,38例(29%)无肿瘤细胞,14例(11%)不确定。
  • 含肿瘤细胞的培养物与其来源肿瘤相似。

关键数值与推荐

  • 细胞病理学报告分为存在肿瘤细胞、不确定、无肿瘤细胞三类。
  • 经细胞病理学验证的培养物高通量药物筛选结果纳入多学科肿瘤委员会报告以指导临床决策。

临床怎么用

  • 在儿童精准肿瘤学中,对送检高通量药物筛选的细胞块进行常规细胞病理学评估。
  • 依据细胞病理学验证结果判断体外药敏数据的临床可转化性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The development of high-throughput drug screening (HTS) using primary cultures provides a promising, clinically translatable approach to tailoring treatment strategies for patients with cancer. However, this has been challenging for solid tumors because of often limited amounts of tissue available. In most cases, in vitro expansion is required before HTS, which may lead to overgrowth and contamination by non-neoplastic cells. METHODS: In this study, hematoxylin and eosin staining and immunohistochemical staining were performed on 129 cytopathology cases from 95 patients. These cytopathology cases comprised cell block preparations derived from primary tumor specimens or patient-derived xenografts as part of a pediatric precision oncology trial. Cytopathology cases were compared with the morphology and immunohistochemical staining profile of the original tumor. Cases were reported as tumor cells present, equivocal, or tumor cells absent. The HTS results from cytopathologically validated cultures were incorporated into a multidisciplinary tumor board report issued to the treating clinician to guide clinical decision making. RESULTS: On cytopathologic examination, tumor cells were present in 77 of 129 cases (60%) and were absent in 38 of 129 cases (29%), whereas 14 of 129 cases (11%) were equivocal. Cultures that contained tumor cells resembled the tumors from which they were derived. CONCLUSIONS: Cytopathologic examination of tumor cell block preparations is feasible and provides detailed morphologic characterization. Cytopathologic examination is essential for ensuring that samples submitted for HTS contain representative tumor cells and that in vitro drug sensitivity data are clinically translatable.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Xie J, Kumar A, Dolman MEM, et al. The important role of routine cytopathology in pediatric precision oncology. Cancer Cytopathol. 2021. PMID: 34043284. doi:10.1002/cncy.22448

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。